Back to results
RecruitingPhase 2

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

NCT06428396

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

City of Hope - Phoenix ( Site 0006)

Goodyear, Arizona, United States

+40 additional locations

Contact

Toll Free Number

1-888-577-8839Trialsites@msd.com
View on ClinicalTrials.gov
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) — TrialFind